{
    "nct_id": "NCT04525183",
    "official_title": "REVITALIZE: A Telehealth Intervention for Women With Advanced Ovarian Cancer and PARP Inhibitor-Related Fatigue",
    "inclusion_criteria": "* Women ≥18 years of age who have been diagnosed with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.\n* Receiving PARPI inhibitors for ≥ 2 months.\n* Able to read/speak English.\n* Have an Eastern Oncology Group (ECOG) performance of 0-2.\n* Report moderate-severe fatigue in the past week (average score ≥4 on a Fatigue Symptom Inventory scale of 0-10)\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients with an untreated clinical condition or comorbid illness (e.g. anemia, hypothyroidism) that could explain their fatigue.\n* Patients with chronic severe fatigue that pre-dates their use of PARPi.\n* The following special populations will be excluded from this research:\n\n  * Adults unable to consent\n  * Individuals who are not yet adults (infants, children, teenagers)\n  * Pregnant women\n  * Prisoners",
    "miscellaneous_criteria": ""
}